Letter to the shareholder on annual report-weblink
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Sandu Pharmaceuticals has sent a letter to shareholders who have not registered their email addresses, providing the weblink (https://sandu.in/annual-report-2/) to access the Annual Report for FY 2024-25. The company's 40th Annual General Meeting (AGM) is scheduled for Tuesday, September 30, 2025, at 4:30 PM, to be conducted via Video Conferencing. The letter also informs shareholders about a one-time special window from July 7, 2025 to January 6, 2026, allowing physical shareholders to re-lodge share transfer requests that were previously rejected or not processed before the April 1, 2019 deadline. Additionally, the company has launched the 'Saksham Niveshak' campaign running from July 28, 2025 to November 6, 2025, to help shareholders update KYC details (bank account, nominee, contact info) and claim any unpaid or unclaimed dividends before they get transferred to IEPFA.
This is a routine administrative communication with no direct impact on the stock price or financials. Shareholders holding physical shares or those with unclaimed dividends should take note of the respective deadlines to avoid losing entitlements or facing transfer complications.